TD
Insider
Thomas DiRaimondo
Chief Scientific OfficerThomas DiRaimondo (Chief Scientific Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in JANX. The largest single filing was $200K of JANX (4,325 sh × $46.21, as filed), executed Sep 27 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Sep 27 2024
Filed Sep 27 2024
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
JANX
JANX
JANX · 0 buys · 1 sell
1 filing
Recent filings
JANXSALE
Janux Therapeutics, Inc.
View filing →
$200K4,325 sh × $46.21
Exec Sep 27 2024
Filed Sep 27 2024 · 5:30 PM ET